English
简体中文
Total: £ 56.28
Published Date: 2022-07-21 | Pages: 65 | Tables: 110 | Medical Devices & Consumables
Subdermal contraceptive implants involve the delivery of a steroid progestin from polymer capsules or rods placed under the skin. The hormone diffuses out slowly at a stable rate, providing contraceptive effectiveness for 1-5 years. The period of protection depends upon the specific progestin and the type of polymer.
Due to the COVID-19 pandemic, the global Subdermal Contraceptive Implants market size is estimated to be worth US$ 649.9 million in 2021 and is forecast to a readjusted size of US$ 998.3 million by 2028 with a CAGR of 6.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Subdermal Contraceptive Implants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Subdermal Contraceptive Implants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Jadelle accounting for % of the Subdermal Contraceptive Implants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Subdermal Contraceptive Implants include Bayer AG, Merck and Shanghai Dahua Pharmaceutical Co., Ltd., etc. In terms of revenue, the global 3 largest players have a % market share of Subdermal Contraceptive Implants in 2021.
This report focuses on Subdermal Contraceptive Implants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Subdermal Contraceptive Implants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Subdermal Contraceptive Implants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Jadelle
Sino-implant
Implanon
Nexplanon
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer AG
Merck
Shanghai Dahua Pharmaceutical Co., Ltd.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Subdermal Contraceptive Implants Market Overview
1.1 Product Overview and Scope of Subdermal Contraceptive Implants
1.2 Subdermal Contraceptive Implants Segment by Type
1.2.1 Global Subdermal Contraceptive Implants Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Jadelle
1.2.3 Sino-implant
1.2.4 Implanon
1.2.5 Nexplanon
1.3 Subdermal Contraceptive Implants Segment by Application
1.3.1 Global Subdermal Contraceptive Implants Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subdermal Contraceptive Implants Market Size Estimates and Forecasts
1.4.1 Global Subdermal Contraceptive Implants Revenue 2017-2028
1.4.2 Global Subdermal Contraceptive Implants Sales 2017-2028
1.4.3 Subdermal Contraceptive Implants Market Size by Region: 2017 Versus 2021 Versus 2028
2 Subdermal Contraceptive Implants Market Competition by Manufacturers
2.1 Global Subdermal Contraceptive Implants Sales Market Share by Manufacturers (2017-2022)
2.2 Global Subdermal Contraceptive Implants Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Subdermal Contraceptive Implants Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Subdermal Contraceptive Implants Manufacturing Sites, Area Served, Product Type
2.5 Subdermal Contraceptive Implants Market Competitive Situation and Trends
2.5.1 Subdermal Contraceptive Implants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Subdermal Contraceptive Implants Players Market Share by Revenue
2.5.3 Global Subdermal Contraceptive Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subdermal Contraceptive Implants Retrospective Market Scenario by Region
3.1 Global Subdermal Contraceptive Implants Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Subdermal Contraceptive Implants Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Subdermal Contraceptive Implants Market Facts & Figures by Country
3.3.1 North America Subdermal Contraceptive Implants Sales by Country
3.3.2 North America Subdermal Contraceptive Implants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Subdermal Contraceptive Implants Market Facts & Figures by Country
3.4.1 Europe Subdermal Contraceptive Implants Sales by Country
3.4.2 Europe Subdermal Contraceptive Implants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Subdermal Contraceptive Implants Market Facts & Figures by Region
3.5.1 Asia Pacific Subdermal Contraceptive Implants Sales by Region
3.5.2 Asia Pacific Subdermal Contraceptive Implants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Subdermal Contraceptive Implants Market Facts & Figures by Country
3.6.1 Latin America Subdermal Contraceptive Implants Sales by Country
3.6.2 Latin America Subdermal Contraceptive Implants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Subdermal Contraceptive Implants Market Facts & Figures by Country
3.7.1 Middle East and Africa Subdermal Contraceptive Implants Sales by Country
3.7.2 Middle East and Africa Subdermal Contraceptive Implants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Subdermal Contraceptive Implants Historic Market Analysis by Type
4.1 Global Subdermal Contraceptive Implants Sales Market Share by Type (2017-2022)
4.2 Global Subdermal Contraceptive Implants Revenue Market Share by Type (2017-2022)
4.3 Global Subdermal Contraceptive Implants Price by Type (2017-2022)
5 Global Subdermal Contraceptive Implants Historic Market Analysis by Application
5.1 Global Subdermal Contraceptive Implants Sales Market Share by Application (2017-2022)
5.2 Global Subdermal Contraceptive Implants Revenue Market Share by Application (2017-2022)
5.3 Global Subdermal Contraceptive Implants Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Subdermal Contraceptive Implants Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bayer AG Subdermal Contraceptive Implants Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Subdermal Contraceptive Implants Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merck Subdermal Contraceptive Implants Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Shanghai Dahua Pharmaceutical Co., Ltd.
6.3.1 Shanghai Dahua Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Shanghai Dahua Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Product Portfolio
6.3.5 Shanghai Dahua Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Subdermal Contraceptive Implants Manufacturing Cost Analysis
7.1 Subdermal Contraceptive Implants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Subdermal Contraceptive Implants
7.4 Subdermal Contraceptive Implants Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Subdermal Contraceptive Implants Distributors List
8.3 Subdermal Contraceptive Implants Customers
9 Subdermal Contraceptive Implants Market Dynamics
9.1 Subdermal Contraceptive Implants Industry Trends
9.2 Subdermal Contraceptive Implants Market Drivers
9.3 Subdermal Contraceptive Implants Market Challenges
9.4 Subdermal Contraceptive Implants Market Restraints
10 Global Market Forecast
10.1 Subdermal Contraceptive Implants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Subdermal Contraceptive Implants by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Subdermal Contraceptive Implants by Type (2023-2028)
10.2 Subdermal Contraceptive Implants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Subdermal Contraceptive Implants by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Subdermal Contraceptive Implants by Application (2023-2028)
10.3 Subdermal Contraceptive Implants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Subdermal Contraceptive Implants by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Subdermal Contraceptive Implants by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Subdermal Contraceptive Implants Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Subdermal Contraceptive Implants Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Subdermal Contraceptive Implants Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Subdermal Contraceptive Implants Market Competitive Situation by Manufacturers in 2021
Table 5. Global Subdermal Contraceptive Implants Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Subdermal Contraceptive Implants Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Subdermal Contraceptive Implants Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Subdermal Contraceptive Implants Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Subdermal Contraceptive Implants Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Subdermal Contraceptive Implants Manufacturing Sites and Area Served
Table 11. Manufacturers Subdermal Contraceptive Implants Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Subdermal Contraceptive Implants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subdermal Contraceptive Implants as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Subdermal Contraceptive Implants Sales by Region (2017-2022) & (K Units)
Table 16. Global Subdermal Contraceptive Implants Sales Market Share by Region (2017-2022)
Table 17. Global Subdermal Contraceptive Implants Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Subdermal Contraceptive Implants Revenue Market Share by Region (2017-2022)
Table 19. North America Subdermal Contraceptive Implants Sales by Country (2017-2022) & (K Units)
Table 20. North America Subdermal Contraceptive Implants Sales Market Share by Country (2017-2022)
Table 21. North America Subdermal Contraceptive Implants Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Subdermal Contraceptive Implants Revenue Market Share by Country (2017-2022)
Table 23. Europe Subdermal Contraceptive Implants Sales by Country (2017-2022) & (K Units)
Table 24. Europe Subdermal Contraceptive Implants Sales Market Share by Country (2017-2022)
Table 25. Europe Subdermal Contraceptive Implants Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Subdermal Contraceptive Implants Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Subdermal Contraceptive Implants Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Subdermal Contraceptive Implants Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Subdermal Contraceptive Implants Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Subdermal Contraceptive Implants Revenue Market Share by Region (2017-2022)
Table 31. Latin America Subdermal Contraceptive Implants Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Subdermal Contraceptive Implants Sales Market Share by Country (2017-2022)
Table 33. Latin America Subdermal Contraceptive Implants Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Subdermal Contraceptive Implants Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Subdermal Contraceptive Implants Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Subdermal Contraceptive Implants Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Subdermal Contraceptive Implants Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Subdermal Contraceptive Implants Revenue Market Share by Country (2017-2022)
Table 39. Global Subdermal Contraceptive Implants Sales by Type (2017-2022) & (K Units)
Table 40. Global Subdermal Contraceptive Implants Sales Market Share by Type (2017-2022)
Table 41. Global Subdermal Contraceptive Implants Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Subdermal Contraceptive Implants Revenue Share by Type (2017-2022)
Table 43. Global Subdermal Contraceptive Implants Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Subdermal Contraceptive Implants Sales (K Units) by Application (2017-2022)
Table 45. Global Subdermal Contraceptive Implants Sales Market Share by Application (2017-2022)
Table 46. Global Subdermal Contraceptive Implants Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Subdermal Contraceptive Implants Revenue Share by Application (2017-2022)
Table 48. Global Subdermal Contraceptive Implants Price by Application (2017-2022) & (US$/Unit)
Table 49. Bayer AG Corporation Information
Table 50. Bayer AG Description and Business Overview
Table 51. Bayer AG Subdermal Contraceptive Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Bayer AG Subdermal Contraceptive Implants Product
Table 53. Bayer AG Recent Developments/Updates
Table 54. Merck Corporation Information
Table 55. Merck Description and Business Overview
Table 56. Merck Subdermal Contraceptive Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Merck Subdermal Contraceptive Implants Product
Table 58. Merck Recent Developments/Updates
Table 59. Shanghai Dahua Pharmaceutical Co., Ltd. Corporation Information
Table 60. Shanghai Dahua Pharmaceutical Co., Ltd. Description and Business Overview
Table 61. Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Product
Table 63. Shanghai Dahua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 64. Production Base and Market Concentration Rate of Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Subdermal Contraceptive Implants Distributors List
Table 67. Subdermal Contraceptive Implants Customers List
Table 68. Subdermal Contraceptive Implants Market Trends
Table 69. Subdermal Contraceptive Implants Market Drivers
Table 70. Subdermal Contraceptive Implants Market Challenges
Table 71. Subdermal Contraceptive Implants Market Restraints
Table 72. Global Subdermal Contraceptive Implants Sales Forecast by Type (2023-2028) & (K Units)
Table 73. Global Subdermal Contraceptive Implants Sales Market Share Forecast by Type (2023-2028)
Table 74. Global Subdermal Contraceptive Implants Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 75. Global Subdermal Contraceptive Implants Revenue Market Share Forecast by Type (2023-2028)
Table 76. Global Subdermal Contraceptive Implants Sales Forecast by Application (2023-2028) & (K Units)
Table 77. Global Subdermal Contraceptive Implants Sales Market Share Forecast by Application (2023-2028)
Table 78. Global Subdermal Contraceptive Implants Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 79. Global Subdermal Contraceptive Implants Revenue Market Share Forecast by Application (2023-2028)
Table 80. Global Subdermal Contraceptive Implants Sales Forecast by Region (2023-2028) & (K Units)
Table 81. Global Subdermal Contraceptive Implants Sales Market Share Forecast by Region (2023-2028)
Table 82. Global Subdermal Contraceptive Implants Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 83. Global Subdermal Contraceptive Implants Revenue Market Share Forecast by Region (2023-2028)
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Subdermal Contraceptive Implants
Figure 2. Global Subdermal Contraceptive Implants Market Share by Type in 2021 & 2028
Figure 3. Jadelle Product Picture
Figure 4. Sino-implant Product Picture
Figure 5. Implanon Product Picture
Figure 6. Nexplanon Product Picture
Figure 7. Global Subdermal Contraceptive Implants Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Subdermal Contraceptive Implants Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Subdermal Contraceptive Implants Market Size (2017-2028) & (US$ Million)
Figure 13. Global Subdermal Contraceptive Implants Sales (2017-2028) & (K Units)
Figure 14. Subdermal Contraceptive Implants Sales Share by Manufacturers in 2021
Figure 15. Global Subdermal Contraceptive Implants Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Subdermal Contraceptive Implants Players: Market Share by Revenue in 2021
Figure 17. Subdermal Contraceptive Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Subdermal Contraceptive Implants Sales Market Share by Region (2017-2022)
Figure 19. Global Subdermal Contraceptive Implants Sales Market Share by Region in 2021
Figure 20. Global Subdermal Contraceptive Implants Revenue Market Share by Region (2017-2022)
Figure 21. Global Subdermal Contraceptive Implants Revenue Market Share by Region in 2021
Figure 22. U.S. Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Subdermal Contraceptive Implants Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Subdermal Contraceptive Implants by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Subdermal Contraceptive Implants
Figure 48. Manufacturing Process Analysis of Subdermal Contraceptive Implants
Figure 49. Subdermal Contraceptive Implants Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
